Artwork

Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The effects of COVID-19 on worldwide oncology clinical trials

28:33
 
Share
 

Manage episode 277799806 series 2813433
Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Steve Fruchtman, President and CEO of Onconova Therapeutics Inc, about how the reallocation of resources within cancer centres around the world due to COVID-19. Steve talked us through the impacts on their early and late stage lead programs which includes short term restrictions such as accessing review data, as well as longer-term impacts including additional monitoring and testing for patients on haematology and oncology trials. Steve gives an insight into how they’re preparing for commercialization of their therapies within China, the affect COVID-19 has had on these partnerships, and how regulatory restrictions and language barriers can present a challenge in this area.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

48 episodes

Artwork
iconShare
 
Manage episode 277799806 series 2813433
Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Steve Fruchtman, President and CEO of Onconova Therapeutics Inc, about how the reallocation of resources within cancer centres around the world due to COVID-19. Steve talked us through the impacts on their early and late stage lead programs which includes short term restrictions such as accessing review data, as well as longer-term impacts including additional monitoring and testing for patients on haematology and oncology trials. Steve gives an insight into how they’re preparing for commercialization of their therapies within China, the affect COVID-19 has had on these partnerships, and how regulatory restrictions and language barriers can present a challenge in this area.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

48 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide